As scrutiny of Purdue Pharma's role in the opioid epidemic intensified during the past dozen years, its owners, members of the Sackler family, withdrew more than $10B from the company, NYT reports, citing a new audit commissioned by the drugmaker.
"We need full transparency into their total assets and must know whether they sheltered them in an effort to protect against creditors and victims," New York Attorney General Letitia James declared.
Purdue filed for bankruptcy protection in September to pause thousands of lawsuits as it tries to build support for a proposed $10B settlement.
Related tickers: McKesson (NYSE:MCK), AmerisourceBergen (NYSE:ABC), Cardinal Health (NYSE:CAH), Mallinckrodt (NYSE:MNK), Endo International (NASDAQ:ENDP), Teva Pharmaceutical Industries (NYSE:TEVA), Johnson & Johnson (NYSE:JNJ).
Try Seeking Alpha PREMIUM for unlimited analysis on MCK